| Primary |
| Depression |
66.7% |
| Hyperthyroidism |
33.3% |
|
| Neutropenic Sepsis |
100.0% |
|
| Secondary |
| Hyperthyroidism |
24.6% |
| Basedow's Disease |
14.0% |
| Product Used For Unknown Indication |
12.6% |
| Renal Transplant |
7.2% |
| Hypertension |
5.8% |
| Depression |
4.8% |
| Drug Use For Unknown Indication |
4.4% |
| Prophylaxis |
3.4% |
| Bipolar Disorder |
2.7% |
| Hypothyroidism |
2.7% |
| Thrombosis Prophylaxis |
2.7% |
| Atrial Fibrillation |
2.0% |
| Autoimmune Thyroiditis |
2.0% |
| Schizophrenia |
2.0% |
| Psychotic Disorder |
1.7% |
| Thyroid Function Test Abnormal |
1.7% |
| Affect Lability |
1.4% |
| B-cell Lymphoma |
1.4% |
| Diabetes Mellitus |
1.4% |
| Hepatitis C |
1.4% |
|
| Iron Deficiency Anaemia |
18.6% |
| Hyperthyroidism |
11.6% |
| Parathyroid Tumour Benign |
8.1% |
| Neutropenic Sepsis |
7.0% |
| Metabolic Alkalosis |
5.8% |
| Thrombocytopenia |
5.8% |
| Suicidal Ideation |
4.7% |
| Vanishing Bile Duct Syndrome |
4.7% |
| White Blood Cell Count Abnormal |
4.7% |
| Oropharyngeal Pain |
3.5% |
| Thyroid Neoplasm |
3.5% |
| Urinary Tract Infection |
3.5% |
| Hepatic Function Abnormal |
2.3% |
| Hepatic Necrosis |
2.3% |
| Oedema Mouth |
2.3% |
| Pneumonia |
2.3% |
| Rash Generalised |
2.3% |
| Respiratory Failure |
2.3% |
| Thyroid Function Test Abnormal |
2.3% |
| Treatment Noncompliance |
2.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
25.9% |
| Product Used For Unknown Indication |
18.5% |
| Parkinson's Disease |
12.0% |
| Hyperthyroidism |
7.9% |
| Hypertension |
4.3% |
| Rheumatoid Arthritis |
4.2% |
| Ill-defined Disorder |
4.0% |
| Atrial Fibrillation |
3.3% |
| Schizophrenia |
2.7% |
| Diabetes Mellitus |
2.6% |
| Non-small Cell Lung Cancer |
2.3% |
| Coronary Artery Disease |
1.8% |
| Basedow's Disease |
1.8% |
| Lung Neoplasm Malignant |
1.6% |
| Prophylaxis |
1.6% |
| Breast Cancer |
1.3% |
| Affective Disorder |
1.1% |
| Chronic Myeloid Leukaemia |
1.1% |
| Colon Cancer |
1.1% |
| Depression |
0.9% |
|
| Wrong Drug Administered |
12.0% |
| Medication Error |
11.3% |
| Death |
7.7% |
| Hyperthyroidism |
7.7% |
| Rhabdomyolysis |
7.0% |
| Weight Decreased |
6.3% |
| Weight Increased |
6.3% |
| Vomiting |
5.6% |
| Sepsis |
3.5% |
| Skin Discolouration |
3.5% |
| Treatment Noncompliance |
3.5% |
| Cardiac Arrest |
2.8% |
| Dehydration |
2.8% |
| Drug Eruption |
2.8% |
| Headache |
2.8% |
| International Normalised Ratio Increased |
2.8% |
| Myocardial Infarction |
2.8% |
| Pulmonary Embolism |
2.8% |
| Swelling Face |
2.8% |
| Toxicity To Various Agents |
2.8% |
|
| Interacting |
| Hyperthyroidism |
50.0% |
| Bipolar I Disorder |
25.0% |
| Product Used For Unknown Indication |
25.0% |
|
| Nausea |
50.0% |
| Psychotic Disorder |
50.0% |
|
